• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
CERS

CERS

Cerus Corporation

NASDAQHealthcareMedical - DevicesUS

USD2.66

-0.04 (-1.48%)

Rating:C

Company Profile

CEO

William Greenman

IPO Date

1997-01-31

Sector

Healthcare

Industry

Medical - Devices

Exchange

NASDAQ

Country

US

Market Metrics

Open

$2.74

Prev. Close

$2.70

Day Low

$2.62

Day High

$2.76

52W Low

$1.15

52W High

$3.15

Market Cap

$0.53B

Volume

2.18M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

38.9%

Avg Negative

10.3%

Avg Neutral

51.0%

News Feed

CERS Stock Price Increases Over 13% Pre-Market: Why It Happened

Pulse2·8/4/2021·↑ positive

Cerus Corporation (CERS) CEO Obi Greenman on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·8/3/2021·↓ negative

Cerus Corporation Announces CMS Has Granted New Technology Add-On Payment for INTERCEPT Fibrinogen Complex

Business Wire·8/3/2021·↑ positive

Cerus Corporation to Release Second Quarter 2021 Financial Results on August 3, 2021

Business Wire·7/20/2021·↑ positive

Cerus Corp.: Market Continues To Overlook Growth And Upside Potential

Seeking Alpha·6/15/2021·↓ negative

Cerus Corporation (CERS) CEO Obi Greenman on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/5/2021·↓ negative

Cerus Corp.: Remaining Bullish Despite Delayed Compliance Date

Seeking Alpha·3/16/2021·↑ positive

Cerus Corporation's (CERS) CEO Obi Greenman on Q4 2020 Results - Earnings Call Transcript

Seeking Alpha·2/25/2021·↓ negative

Cerus Corporation to Release Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021

Business Wire·2/11/2021·↓ negative

Cerus Update: Tailwinds Now Include FDA Approval Of Cryoprecipitate Product

Seeking Alpha·12/16/2020·↑ positive